Results 171 to 180 of about 722,278 (319)

Untraceable Blind Signature Schemes Based on the Discrete Logarithm Problem

open access: yes, 2010
[[abstract]]With the help of a blind signature scheme, a requester can obtain a signature on a message from a signer such that the signer knows nothing about the content of the messages and is unable to link the resulting message-signature pair; namely ...
Cheng-Chi Lee; Min-Shiang Hwang; Wei-Pang Yang
core  

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Integrating DEI Principles in the Forensic World

open access: yesForensic Science International: Synergy
Kris Cano
doaj   +1 more source

Untraceable Blind Signature Schemes Based on the Discrete Logarithm Problem

open access: yes, 2012
[[abstract]]With the help of a blind signature scheme, a requester can obtain a signature on a message from a signer such that the signer knows nothing about the content of the messages and is unable to link the resulting message-signature pair; namely ...
Cheng-Chi Lee;Wei-Pang Yang;Min-Shiang Hwang
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

An Improvement of Nonrepudiable Threshold Proxy Signature Scheme with Known Signers

open access: yes, 2012
[[abstract]]In a (t, n) threshold proxy signature scheme, which is a variant of the proxy signature scheme, the proxy signature key is shared among a group of n proxy signers delegated by the original signer. Any t or more proxy signers can cooperatively
黃明祥;Hwang, Min-Shiang
core  

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Raman‐based label‐free microscopic analysis of the pancreas in living zebrafish larvae

open access: yesFEBS Open Bio, EarlyView.
Forward stimulated Raman scattering (F‐SRS) and epi coherent anti‐Stokes Raman scattering (E‐CARS) allow label‐free discrimination of distinct subcellular structures in the pancreas of living zebrafish larvae. Given the straightforward applicability, we anticipate broad implementation of Raman microscopy in other organs and across various biomedical ...
Noura Faraj   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy